Cleared Traditional

K171450 - Glooko Mobile Insulin Dosing System

K171450 is the FDA 510(k) clearance for Glooko Mobile Insulin Dosing System by Glooko, Inc.. It is a Class 2 General Hospital device (product code NDC) cleared through the Traditional 510(k) pathway after a 261-day FDA review.

K171450 · Glooko, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2018
Decision
261d
Days
Class 2
Risk

K171450 is an FDA 510(k) clearance for the Glooko Mobile Insulin Dosing System. Classified as Calculator, Drug Dose (product code NDC), Class II - Special Controls.

Submitted by Glooko, Inc. (Mountain View, US). The FDA issued a Cleared decision on February 2, 2018 after a review of 261 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 868.1890 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Glooko, Inc. devices

Submission Details

510(k) Number K171450 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 17, 2017
Decision Date February 02, 2018
Days to Decision 261 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
132d slower than avg
Panel avg: 129d · This submission: 261d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NDC Calculator, Drug Dose
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - NDC Calculator, Drug Dose

All 24
Devices cleared under the same product code (NDC) and FDA review panel - the closest regulatory comparables to K171450.
d-Nav System
K181916 · Hygieia, Inc. · Feb 2019
EndoTool SubQ
K180366 · Al Pacheco and Associates · Sep 2018
InPen Dose Calculator
K181327 · Companion Medical, Inc. · Jul 2018
ACCU-CHEK ADVISOR INSULIN GUIDANCE SOFTWARE
K043529 · Roche Diagnostics Corp. · Apr 2005
ABBOTT PHARAMACOKINETICS SYSTEMS
K851573 · Abbott Laboratories · Jan 1986